Related Experiment Video
Updated: Apr 26, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Matrix metalloproteinases and peripheral arterial disease
I Giagtzidis1, C Karkos, G Pitoulias
1Fifth Surgical Department, Hippokrateio General Hospital, Thessaloniki, Greece - kimisnet@gmail.com.
Abstract:
It has been postulated that atherosclerosis should be considered as a chronic inflammatory process and peripheral arterial disease (PAD) is a manifestation of such an atherosclerotic vascular disease. Matrix metalloproteinases (MMPs) are significant circulating biomarkers which play a pivotal role in the initiation, progression and clinical manifestations of PAD. This review summarizes the current body of evidence with regard to the association between MMPs and PAD.
Insights
Atherosclerosis is an inflammatory disease where matrix metalloproteinases (MMPs) are key biomarkers. This review explores the link between MMPs and peripheral arterial disease (PAD) progression and manifestations.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
- Inflammation Research
Background:
- Atherosclerosis is increasingly recognized as a chronic inflammatory vascular disease.
- Peripheral arterial disease (PAD) represents a significant clinical manifestation of atherosclerotic vascular disease.
- Matrix metalloproteinases (MMPs) are implicated in the pathogenesis of vascular conditions.
Purpose of the Study:
- To review the current scientific literature on the association between matrix metalloproteinases (MMPs) and peripheral arterial disease (PAD).
- To elucidate the role of MMPs in the initiation, progression, and clinical presentation of PAD.
Main Methods:
- Comprehensive literature search of relevant scientific databases.
- Synthesis and analysis of existing research on MMPs and PAD.
- Review of studies investigating MMPs as biomarkers in PAD.
Main Results:
- Matrix metalloproteinases (MMPs) are significantly associated with peripheral arterial disease (PAD).
- Specific MMPs play critical roles in the development and advancement of PAD.
- MMPs are identified as important circulating biomarkers for PAD.
Conclusions:
- Matrix metalloproteinases (MMPs) are integral to the inflammatory processes underlying peripheral arterial disease (PAD).
- Understanding the MMP-PAD axis offers potential for novel diagnostic and therapeutic strategies.
- Further research into MMPs could enhance the management of atherosclerotic vascular disease.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
07:39Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels
Published on: January 22, 2019
Related Concept Videos
Peripheral Artery Disease I: Introduction
Role of Matrix Metalloproteases in Degradation of ECM
Peripheral Artery Disease III: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management